European Medical Solutions
ALEMS.BR · BRU
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | €45,131 | €40,564 | €37,056 | €38,019 |
| % Growth | 11.3% | 9.5% | -2.5% | – |
| Cost of Goods Sold | €30,175 | €27,053 | €23,280 | €24,216 |
| Gross Profit | €14,956 | €13,511 | €13,776 | €13,803 |
| % Margin | 33.1% | 33.3% | 37.2% | 36.3% |
| R&D Expenses | €0 | €2 | €40 | €0 |
| G&A Expenses | €357 | €295 | €11,256 | €423 |
| SG&A Expenses | €595 | €520 | €11,483 | €11,284 |
| Sales & Mktg Exp. | €238 | €225 | €227 | €10,861 |
| Other Operating Expenses | €13,108 | €13,125 | €7,611 | €2,490 |
| Operating Expenses | €13,703 | €13,647 | €19,134 | €13,774 |
| Operating Income | €1,253 | -€135 | -€5,292 | €29 |
| % Margin | 2.8% | -0.3% | -14.3% | 0.1% |
| Other Income/Exp. Net | -€502 | -€575 | -€292 | -€271 |
| Pre-Tax Income | €751 | -€710 | -€5,584 | -€242 |
| Tax Expense | €205 | €2 | -€1 | -€1 |
| Net Income | €546 | -€709 | -€5,577 | -€241 |
| % Margin | 1.2% | -1.7% | -15.1% | -0.6% |
| EPS | 0.13 | -0.18 | -1.32 | -3.52 |
| % Growth | 172.2% | 86.4% | 62.5% | – |
| EPS Diluted | 0.13 | -0.18 | -1.32 | -3.52 |
| Weighted Avg Shares Out | 4,232 | 4,028 | 4,232 | 68 |
| Weighted Avg Shares Out Dil | 4,232 | 4,232 | 4,232 | 68 |
| Supplemental Information | – | – | – | – |
| Interest Income | €0 | €0 | €3 | €0 |
| Interest Expense | €686 | €432 | €237 | €200 |
| Depreciation & Amortization | €2,331 | €2,195 | €4,094 | €1,933 |
| EBITDA | €3,768 | €2,060 | -€1,253 | €2,051 |
| % Margin | 8.3% | 5.1% | -3.4% | 5.4% |